Introduction
MBP-1 is ubiquitously expressed in dierent human tissues (Ray and Miller, 1991; Ray et al., 1994) and located at human chromosome 1p35-pter (White et al., 1997) . MBP-1 appears to be involved in multiple functions. First, MBP-1 binds to the c-myc promoter sequences and transcriptionally represses c-myc gene (Ray and Miller, 1991; Chaudhury and Miller, 1995; Subramanian and Miller, 2000) . Second, MBP-1 also acts as a corepressor. MBP-1, when brought to the promoter by Gal4 DNA-binding domain, can signi®cantly repress transcriptional activity (Ghosh et al., 1999) . Structure/function analysis of MBP-1 mutants revealed that the transcriptional repressor domains are located in the N-terminus (amino acids 1 ± 47) and C-terminus (amino acids 232 ± 338). When the N-terminal repressor domain of MBP-1 was transferred to a potent activator, transcription was strongly inhibited. Further, MBP-1 physically associates with a recently identi®ed MBP-1 interacting cellular protein, MIP-2A, and relieves transcriptional repression (Ghosh et al., 2001) . Third, ectopic expression of MBP-1 in murine ®broblasts (NIH3T3 cells) induces massive cell death, DNA fragmentation and enforced expression of Bcl-2 protects against MBP-1 mediated cell death . Furthermore, MBP-1 regresses tumor growth in nude mice suggesting its potential as a gene therapeutic candidate. Although these observations shed light on the function of MBP-1, the signaling pathway of MBP-1 mediated apoptotic cell death remains elusive.
Apoptosis, a morphologically and biochemically distinct form of cell death, is an important physiologic process in both normal development and pathological consequences (Hatano et al., 2000) . A diverse set of stimuli can trigger the apoptotic process in virtually all nucleated cells (Steller, 1995; Thompson, 1995) . One of the key regulatory steps for apoptosis is the activation of caspases. Active caspases then cleave many important intracellular substrates, leading to the characteristic morphological changes associated with apoptotic cells (Thornberry and Lazebnik, 1998) . The relative expression levels of pro-and anti-apoptotic genes appear to be particularly important in controling the apoptotic phenomenon (Mercatante et al., 2001) . Proteins of the Bcl-2 family are major regulators of the mitochondria-initiated caspase activation pathway (Adams and Cory, 1998) . Bcl-x, a member of the Bcl-2 family genes, plays crucial roles in both inhibiting and activating the apoptotic response to cellular insults (Adams and Cory, 1998; Antonsson and Martinou, 2000) . Bcl-x is alternatively spliced to produce two distinct mRNAs and two variant proteins, Bcl-x L and Bcl-x s , that have antagonistic functions. The longer protein, Bcl-x L inhibits apoptosis, whereas the shorter form, Bcl-x s activates apoptotic cell death (Boise et al., 1993) . Bcl-x L is highly expressed in many types of cancers, including multiple myeloma (Tu et al., 1998) , small cell lung carcinoma (Reeve et al., 1996) and breast cancer (Olopade et al., 1997) . Upon receiving apoptotic stimuli, the outer membrane of mitochondria becomes permeable to cytochrome c and is released to cytosol (Liu et al., 1996; Reed, 1997) . Bcl-x L blocks the increase in cytosolic cytochrome c accumulation associated with induction of apoptosis (Kharbanda et al., 1997; Kim et al., 2000) . In this study, we have examined the signaling pathway involved in MBP-1 mediated apoptotic cell death.
Results

Exogenous expression of MBP-1 induces cell death in human carcinoma cells
We previously have shown that ectopic expression of MBP-1 induces massive cell death in murine ®broblasts . To investigate the signaling pathway for MBP-1 mediated apoptosis, we took advantage of a recombinant adenovirus mediated gene delivery system. Adenoviruses are used extensively to deliver genes into mammalian cells, particularly where there is a requirement for high level expression of transgene products in cultured cells (Graham, 2000) . Full length MBP-1 was cloned into a replication de®cient recombinant adenovirus (AdMBP-1) and the expression of MBP-1 was veri®ed by Western blot analysis (Figure 1a) . A higher expression level of MBP-1 was observed in cells transduced with AdMBP-1 (lanes 2 ± 4) as compared to negative control dl312 adenovirus (Liu et al., 1995) where endogenous MBP-1 was present (lane 1). A number of tumor cell lines of human origin were infected with AdMBP-1 or dl312. Cell viability was counted after 48 h of infection by Trypan blue exclusion (Figure 1b) . Exogenous expression of MBP-1 induced a signi®cant cell death in human carcinoma cells as compared to the cells infected with dl312 control virus.
To investigate whether expression of MBP-1 in human carcinoma cells induces DNA fragmentation, a hallmark of apoptosis (Shi et al., 1992) , MCF-7 cells were infected with either AdMBP-1 or dl312. DNA was isolated from cells after 48 h of infection and analysed by agarose gel electrophoresis. Results exhibited internucleosomal DNA fragmentation in the cells expressing MBP-1 (Figure 2a) . However, cells transduced with control dl312 virus did not exhibit detectable DNA fragmentation. Apoptotic cell death induced by MBP-1 was further quanti®ed by a cell death detection ELISA, which is based on the quantitative sandwich-enzyme-immunoassay principle using mouse monoclonal antibodies against DNA and histone. This allows the speci®c determination of mono-and oligonucleosomes in the cytoplasmic fraction of apoptotic cells. A signi®cant level of DNA fragmentation was detected in cells infected with AdMBP-1, when compared to the cells infected with control dl312 virus (Figure 2b ). Similar observations were made from HeLa cells infected with AdMBP-1 or dl312. Together, these observations suggest that MBP-1 induces apoptotic cell death in human carcinoma cells.
MBP-1 induces release of cytochrome c from mitochondria
During apoptosis induced by diverse stimuli, cytochrome c is released from mitochondria into the cytosol (Kharbanda et al., 1997; Kluck et al., 1997; Figure 1 Exogenous expression of MBP-1 and induction of cell death. (a) Cells were infected with negative control dl312 at 100 moi (lane 1) or AdMBP-1 at 10, 50 and 100 moi (lanes 2, 3 and 4, respectively). Cell lysates were prepared after 48 h of infection, and equal amounts of protein were separated by SDS ± PAGE. Proteins were transferred onto nitrocellulose membrane for Western blot analysis using an antibody to MBP-1. (b) MBP-1 induces cell death in human tumor cell lines. Cells were infected either with dl312 or AdMBP-1 at 100 moi and cell viability was counted by Trypan blue exclusion after 48 h of infection. Per cent of viable cells was calculated with respect to the control cells Yang et al., 1997; Bossy-Wetzel et al., 1998) , and is thought to be a crucial event in the apoptotic pathway. Here, we investigated whether MBP-1 releases cytochrome c from mitochondria to cytosol. HeLa or MCF-7 cells were transduced with either dl312 or AdMBP-1 for 48 h, treated with mitotracker dye for 30 min and immunostained with a mouse monoclonal antibody to cytochrome c for confocal microscopy ( Figure 3a) . Cytochrome c displayed punctate staining localized to mitochondria of cells infected with control dl312 virus, as evident from the coexpression with marker for mitochondria. However, cells expressing MBP-1 displayed a diuse cytosolic localization of cytochrome c, which was no longer con®ned to mitochondria. Thus, MBP-1 expression appears to induce cytochrome c release from mitochondria into the cytosol.
Subcellular fractionation of MCF-7 cells was also performed to con®rm the localization of cytochrome c after MBP-1 transduction. Cytochrome c in control cells cofractionated with mitochondria in the pelleted membrane (Figure 3b) , and did not appear in the soluble S-100 cytosolic fraction (Figure 3c ). However, AdMBP-1 infected cells displayed a marked release of cytochrome c from mitochondria into the cytosol (Figure 3c) . A low level of cytochrome c was present in the mitochondrial membrane fraction of AdMBP-1 infected cells (Figure 3b ) which corroborated with the results from our confocal microscopy. Similar results were obtained from HeLa cells infected with AdMBP-1 or dl312. These observations demonstrate that MBP-1 induces release of cytochrome c from mitochondria into the cytosol of apoptotic cells.
MBP-1 mediates activation of procaspase-9
To further examine the apoptotic signaling pathway of MBP-1, we determined the activation level of the initiator procaspase-9, an upstream activator of procaspase-3, in the AdMBP-1 or dl312 infected HeLa or MCF-7 cell lysates by Western blot analysis ( Figure  4a ). Upon activation, the proenzyme is cleaved to its active polypeptides of 35 and 10 kD. The antibody used in this analysis recognizes the proform of caspase-9 as a 46 ± 48 kD polypeptide. Control cell lysates exhibited the expression level of procaspase-9. In contrast, a gradual decrease in the level of the procaspase-9 was observed in cells transduced with increasing doses of AdMBP-1. The blot was reprobed with an antibody to actin and suggested similar amount of protein loaded in each lane (®gure not shown). Our results suggest that MBP-1 induced apoptotic pathway involves activation of the procaspase-9 into its active subunits.
MBP-1 induces activation of caspase-3 and PARP cleavage
We next examined the activation of the downstream eector molecule caspase-3 induced by MBP-1. HeLa cells were infected with dl312 or AdMBP-1 and cell lysates prepared after 48 h of infection were subjected to Western blot analysis using a rabbit polyclonal antibody to caspase-3. Active caspase-3 consists of 17 and 12 kD subunits which are derived from a 32 kD proenzyme. The caspase-3 antibody recognizes both the 32 kD procaspase-3 and the 17 kD subunit of active or AdMBP-1 virus were prepared and analysed for fragmentation of cellular DNA using a cell death detection kit (Roche). DNA fragmentation is presented as per cent control (described in Materials and methods) and small bars represent standard error from triplicate analysis caspase-3. Activation of caspase-3 was observed in HeLa cell lysates expressing MBP-1 (Figure 4b ). However, cells infected with dl312 did not exhibit a detectable cleavage of the procaspase-3 into its active subunit. We did not perform similar analysis in MCF-7 cells since this cell line does not express caspase 3 (Li et al., 1997) . Cleavage of the DNA repair enzyme poly (ADP-ribose) polymerase (PARP) from a 116 kD protein to a signature 86 kD fragment is associated with a variety of apoptotic responses. PARP is a nuclear protein and a downstream substrate of activated caspase-3. To examine the eect of MBP-1 on the apoptotic signaling pathway, PARP cleavage was investigated in cells expressing MBP-1 by Western blot analysis using a speci®c antibody. Cells expressing MBP-1 displayed a signi®cant cleavage of the native 116 kD PARP to its 86 kD signature peptide ( Figure  4c ). In contrast, cells infected with dl312 did not display a detectable PARP cleavage. Similar PARP cleavage was also observed upon MBP-1 expression in MCF-7 cells, which may follow the activation of caspase-7 by caspase-9 as suggested by other investigators (Germain et al., 1999; Slee et al., 1999) . Together these data demonstrate that exogenous expression of MBP-1 activates downstream caspases and PARP cleavage.
MBP-1 selectively modulates expression of Bcl-x L
Since MBP-1 mediated apoptotic cell death can be protected by Bcl-2 and MBP-1 does not share a homology with the BH (Bcl-2 homology) domain, we hypothesize that MBP-1 may transcriptionally modulate the Bcl-2 family proteins. To examine this, a ribonuclease protection assay was performed. MCF-7 cells were infected with either dl312 or AdMBP-1 and total cellular RNA was extracted after 48 h of infection. A multi-probe template set containing human Bcl-x L / s , Bcl-2, p21, Bax and L32 (house keeping gene) was used in the RNAse protection assay. An approximately fourfold reduction in Bcl-x L mRNA level was observed in cells expressing MBP-1 as compared to that in the cells infected with dl312 (Figure 5a ). However, signi®cant We also investigated whether MBP-1 modulates other Bcl-2 family genes at the mRNA levels. A mini gene array (Superkine Array, Inc.) containing several Bcl-2 family genes (Bcl-2, Bcl-x L , Bax, Bak, Bik, Bcl-w, Bid, Bag-1 and A1) was screened with RNA isolated from MCF-7 cells infected with AdMBP-1 or dl312. Results suggested that MBP-1 does not exhibit a signi®cant eect on other Bcl-2 family genes in MCF-7 cells (data not shown). To examine whether MBP-1 mediated reduction of Bcl-x L mRNA correlates with downregulation of Bcl-x L protein, MCF-7 cells were infected with AdMBP-1 or dl312. Cell lysates were prepared after 48 h of infection and subjected to Western blot analysis using an antibody to Bcl-x (Santa Cruz). A protein of *32.5 kD, corresponding to the Bcl-x L gene product, was downregulated approximately threefold (scanned in Personal Densitometer, Molecular Dynamics) in MCF-7 cells expressing MBP-1 compared to the cells transduced with control virus (Figure 5b ). Similar amount of protein was present in each lane as evident from the blot reprobed with an antibody to actin. Although the Bcl-x antibody used in this experiment can recognize the Bclx s gene product of *25 kD, we did not detect Bcl-x s in MCF-7 cells. This result corroborated with our mRNA data. An earlier report also suggested that MCF-7 cells do not express Bcl-x s protein (Ealovega et al., 1996) . Thus, downregulation of Bcl-x L appears to be due to introduction of MBP-1 in MCF-7 cells.
Since MBP-1 mediated apoptosis can be blocked by exogenous expression of Bcl-2 (Ray, 1995), we asked whether MBP-1 downregulates the endogenous Bcl-x L expression in presence of exogenous Bcl-2. To address this question, MCF-7 cells were transfected with Bcl-2 plasmid DNA (CMV-Bcl-2) and neomycin resistant colonies were selected over a period of 3 weeks. MCF-7 cells expressing exogenous Bcl-2 (MCF-Bcl-2) were infected with either AdMBP-1 or dl312. Cell lysates were prepared after 48 h of infection and analysed for Bcl-x L protein by Western blot using an antibody to Bcl-x (Figure 5c ). Approximately threefold reduction in the Bcl-x L protein expression was observed in the MCF-Bcl-2 stable transfectants expressing MBP-1 as compared to the control cells infected with dl312. Protein concentration was normalized by reprobing the blot with an antibody to actin. Expression of Bcl-2 protein in the MCF-Bcl-2 stable transfectants was also examined using a speci®c antibody by Western blot analysis. Similar level of Bcl-2 expression was observed in MCF-Bcl-2 cells infected with AdMBP-1 or dl312 (Figure 5c, bottom panel) . On the other hand, endogenous Bcl-2 expression in parental MCF-7 cells could not be detected in our experimental conditions (®gure not shown). These results suggest that exogenous expression of Bcl-2 prevents MBP-1 mediated apoptosis, but does not block MBP-1 mediated downregulation of endogenous Bcl-x L in MCF-7 cells.
MBP-1 represses Bcl-x promoter activity
To investigate MBP-1 mediated transcriptional regulation of Bcl-x L expression, we examined the eect of MBP-1 on Bcl-x promoter by an in vitro reporter gene assay. Though Bcl-x L and Bcl-x s transcripts are regulated by Bcl-x promoter (Boise et al., 1993) , we did not detect Bcl-x s transcript in MCF-7 cells in our RNAse protection assay. Cells were cotransfected with CMVMBP-1 eector plasmid and Bcl-x Luc reporter gene construct (Yasushi et al., 1997) , which contains 639 bp upstream from the transcription start site. Luciferase assay was performed after 48 h of transfection. Results from this assay suggested that MBP-1 represses the Bcl-x promoter activity in a concentration dependent manner (Figure 6a ). This observation corroborates with the results of our RNAse protection assay indicating that MBP-1 represses Bcl-x L expression at the mRNA level. The observed repression of Bcl-x promoter activity by MBP-1 was much higher from in vitro reporter assay as compared to endogenous repression of Bcl-x L in MCF-7 cells detected by RNAse protection assay and Western blot analysis. An in vitro reporter assay suggests the eect of a protein on a speci®c promoter depending on the cell type used, transfection eciency and the reporter gene itself. This may account for the magnitude of dierences in results between luciferase assay and RNAse protection assay or Western blot analysis.
Analysis of Bcl-x promoter sequences reveals that Ets family proteins play an important role in regulation of this gene (Chen and Boxer, 1995; Grillot et al., 1997) . In fact, eight Ets-binding sites (EBS) are located within this 639-bp Bcl-x promoter fragment (Sevilla et al., 1999) . Interestingly, when a deletion mutant of the Bcl-x promoter, having 298-bp upstream from the transcription start site containing one EBS linked to luciferase gene, was cotransfected with CMVMBP-1, no signi®cant transregulatory eect was observed under similar experimental conditions (Figure 6b ). Therefore, it is possible that MBP-1 modulates the Bcl-x promoter through Ets family proteins. To test this hypothesis, we performed an in vitro reporter assay by cotransfecting TK promoter with three Ets binding sites (Ets-TK luc) and MBP-1 in MCF-7 cells. Our results demonstrated MBP-1 mediated downregulation of luciferase activity occurs in a dose dependent manner, suggesting that MBP-1 may modulate the endogenous Ets function (Figure 7a ). Ets-1 functions as a negative regulator of Bcl-2 expression (Chen and Boxer, 1995) . Our results also suggest that exogenous expression of Ets-1 downregulates Ets-TK luc activity and coexpression of MBP-1 with Ets-1 enhances the repressor activity (Figure 7a ). MBP-1 showed very little transcriptional activity on TK promoter construct (TK Luc) without the Ets binding sites in a similar in vitro reporter assay (Figure 7b ). Thus, these results suggest that Ets-1 protein is involved in MBP-1 mediated Bclx L transcriptional repression in MCF-7 cells. Further in depth mechanism of MBP-1 mediated Bcl-x L regulation through Ets protein family remains to be elucidated.
Discussion
Many transcription factors play an essential role in determining the fate of a cell by inducing proliferative and/or dierentiation responses, and regulating processes of programmed cell death or apoptosis. MBP-1 is an *37 kDa cellular protein, initially identi®ed from HeLa cell expression library (Ray and Miller, 1991) . MBP-1 has many intriguing properties such as transcriptional repressor activity, induction of apoptosis and regression of tumor growth (Ray and Miller, 1991; Chaudhury and Miller, 1995; Ghosh et al., 1999) . Sequence analysis suggests that MBP-1 has a high homology with Eno1 cDNA (Ray and Miller, 1991) , designated as human a enolase cDNA (Giallongo et al., 1994) . However, the enolase enzymatic activity was not demonstrated from this Eno1 cDNA clone. Recent reports suggest that a 37 kDa protein is alternatively translated from Eno1 cDNA, which binds and downregulates c-myc P2 promoter activity (Feo et al., 2000; Subramaniun and Miller, 2000) . Whether full length Eno1 gene product could have similar function like MBP-1 in carcinoma cells is yet to be determined. MBP-1 is a transcription factor which induces apoptosis in mammalian cells. Here, we investigated the signaling pathway involved in the mechanism of MBP-1 mediated apoptotic cell death. Our results demonstrate that MBP-1 releases cytochrome c from mitochondria into the cytosol. Mitochondria play a key role in the regulation of apoptosis (Cai et al., 1998; Green and Reed, 1998; Reed et al., 1998; Susin et al., 1998; Strasser et al., 2000) . Cytochrome c, released from the mitochondria, interacts with the adaptor protein, Apaf1 and forms a complex with procaspase-9. The complex of cytochrome c, Apaf-1 and procaspase-9 leads to the activated caspase-9, which subsequently cleaves procaspase-3. Activated caspase-3 cleaves PARP and directs fragmentation of DNA. Transduction of MBP-1 induces activation of caspase-9 and caspase-3.
As a result, PARP cleavage and DNA fragmentation occur upon exogenous expression of MBP-1 in HeLa cells. On the other hand, MBP-1 mediated apoptosis in MCF-7 cells also involves activation of procaspase-9 and PARP cleavage. This may occur through caspase-9 mediated activation of caspase-7 (Germain et al., 1999; Slee et al., 1999) .
Opening of the mitochondrial permeability transition pore, which is regulated by members of the Bcl-2 family, causes the release of cytochrome c from the intermembrane space and caspase-9 activation Zamzami et al., 1998) . Anti-apoptotic Bcl-2/ Bcl-x L protein resides in mitochondria and can prevent the release of cytochrome c (Hatano et al., 2000) . Several groups of investigators have reported that overexpression of Bcl-x L or Bcl-2 confers protection upon mitochondria, making it more dicult for many stimuli to induce mitochondrial permeability transition pore opening and the release of apoptosis-inducing factors, such as cytochrome c (Shimizu et al., 1996; Kluck et al., 1997; Yang et al., 1997; Reed et al., 1998) . Inhibition of endogenous Bcl-x L results in substantial cell death (Ackermann et al., 1999) . In addition, Bclx L -de®cient cells become sensitive to apoptosis upon treatment with ceramide and staurosporin that had no Here, we have shown that MBP-1 selectively downregulates Bcl-x L expression at the transcriptional level and reduces protein expression in MCF-7 cells. Bcl-x L and Bcl-x s transcripts are alternatively spliced from the same Bcl-x genomic sequences. However, we did not detect Bcl-x s mRNA or protein as reported earlier with MCF-7 cells (Ealovega et al., 1996) . We examined whether reduction of Bcl-x L expression in MCF-7 cells was due to the transduction of MBP-1 or in response to cell death. For this, we overexpressed Bcl-2 in MCF-7 cells and subsequently infected with AdMBP-1. Our data demonstrate that overexpression of Bcl-2 protects MCF-7 cells from MBP-1 induced apoptosis, however, downregulation of Bcl-x L remains unaected. MBP-1 mediated Bcl-x L repression results in activation of the downstream mitochondrial apoptotic events: cytochrome c dependent caspase-9 processing; and probably, at the same time, by relieving Bcl-x L mediated inhibition of the interaction between Apaf-1 and procaspase-9 (Hu et al., 1998) . We therefore suggest downregulation of Bcl-x L in MCF-7 cells, at least in part, plays a crucial role in MBP-1 induced cell death. However, we do not rule out the involvement of other genes for MBP-1 induced apoptosis in dierent cell types. Bcl-x and Bcl-2 promoters contain a number of Ets binding sites and Ets family proteins have been shown as regulators of these genes (Chen and Boxer, 1995; Grillot et al., 1997) . Our results suggest that MBP-1 does not exert a repressor activity on Bcl-x promoter upon deletion of Ets binding sites. Additional studies reveal that exogenous expression of Ets-1 negatively regulates Bcl-x L expression. Thus, MBP-1 represses Bcl-x L expression by altering function of Ets-1 protein.
Alteration in apoptotic pathways is frequently associated with the development of cancers, autoimmune, and neurodegenerative diseases (Thompson, 1995; Chao and Korsmeyer, 1998; . Many cancer cells up-regulate the anti-apoptotic members as a mechanism to guard against programmed cell death (Ackermann et al., 1999) . High level of Bcl-x L expression is associated with an increased risk of metastasis in breast cancer (Olopade et al., 1997) as well as with an increased resistance to apoptosis induced by chemotherapy (Schmitt et al., 1998; Liu et al., 1999a) . Characterization of MBP-1 induced apoptotic signaling pathway suggests the regulation of cell growth by modulating the Bcl-x L transcription. Thus, MBP-1 may have potential as a gene therapeutic candidate in the regression of neoplastic growth. 
Materials and methods
Cell culture
Cell lines used in this study were procured from ATCC. Human breast carcinoma (MCF-7), cervical carcinoma (HeLa), hepatoblastoma (HepG2), ®brosarcoma (HT-1080), prostate cancer (LNCaP, DU145 and PC3), human embryonic kidney (293) and mouse embryonic ®broblast (NIH3T3) cells were grown in DMEM with 10% fetal bovine serum.
Construction of MBP-1 recombinant adenovirus
The 36 Kb ds DNA genome of adenovirus 5 is relatively easy to manipulate by recombinant DNA technique and helperindependent vectors can accommodate up to 8 Kb of foreign DNA (Graham, 2000) . MBP-1 cDNA in pcDNA3 vector was excised with HindIII ± XhoI (blunt end) and inserted into the HindIII ± EcoRV sites of an adenoviral shuttle vector pAdCMV-BGHpA (Liu et al., 1999b) . The resulting plasmid DNA was then cotransfected with PJM17 plasmid into 293 cells as described previously (Liu et al., 1999b) . Recombinant plaques (AdMBP-1) were isolated and veri®ed by restriction enzyme digestion for presence of MBP-1 gene. Positive plaque was expanded and puri®ed by two cycles of CsCl density gradient centrifugation. Puri®ed virus was stored in 10% glycerol at 7808C. The expression of the MBP-1 gene in the recombinant adenovirus was veri®ed by Western blot analysis using an antibody to MBP-1.
DNA fragmentation
DNA prepared from cells was analysed for nucleosomal fragmentation as previously described . HeLa or MCF-7 cells were infected with AdMBP-1 or dl312 at 100 multiplicity of infection (moi). After 48 h of infection, cells were lysed in 10 mM Tris (pH 8.0), 1 mM EDTA, 100 mM NaCl, 1.0% SDS and 200 mg/ml proteinase K. Genomic DNA was isolated and analysed on a 1.4% agarose gel by electrophoresis. Apoptotic cell death was also analysed quantitatively using a cell death detection ELISA (Roche) following manufacturer's protocol.
Immunofluorescence for cytochrome c HeLa or MCF-7 cells were infected with either dl312 or AdMBP-1 at 100 moi for immuno¯uorescence study. After 48 h of infection, cells were treated with mitotracker for 30 min. Cells were then washed and ®xed with 3.7% formaldehyde in PBS for 30 min. Fixed cells were permeabilized with 0.2% Triton X-100 in PBS for 5 min. After washing, cells were incubated with a mouse monoclonal antibody to cytochrome c (Promega), followed by staining with an anti-mouse secondary antibody conjugated with Alexa-568 (Molecular Probes). Finally, washed cells were mounted for confocal microscopy (Bio-Rad 1024) as described previously (Ghosh et al., 2001) .
Preparation of cytoplasmic fraction from cells
MCF-7 or HeLa cells were infected with dl312 (at 100 moi) or AdMBP-1 (at 50 or 100 moi). After 48 h of infection, cells were harvested, resuspended in ice-cold isotonic buer (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 250 mM Sucrose and a cocktail of protease inhibitors) and fractionated as described earlier (Bossy-Wetzel et al., 1998). The pellet obtained was used as the mitochondrial membrane fraction and the supernatant was used as the cytosolic fraction (S-100). Equal amount of the cytosolic protein extracts and membrane fractions were resolved by SDS ± PAGE (15%), and electroblotted onto nitrocellulose membrane. Cytochrome c was detected by immunoblotting the membrane using a speci®c antibody to cytochrome c (Santa Cruz), followed by enhanced chemiluminescence (Amersham).
PARP cleavage and activation of caspases
HeLa or MCF-7 cells were transduced with AdMBP-1 or dl312. After 48 h of infection, cells were lysed in SDS ± PAGE sample buer and subjected to Western blot analysis using a monoclonal antibody to PARP (Ray et al., 1998) or antibodies to caspase-9 and caspase-3 (Pharmingen).
RNAse protection assay
MCF-7 or HeLa cells were infected with AdMBP-1 or dl312 at 100 moi and total RNA was isolated 48 h after infection using the PUREscript RNA isolation kit (Gentra Systems, MN, USA). A custom multi-probe template set (Pharmingen) containing human Bcl-2, Bcl-x L / s , p21, Bax, and L32 was used in RNAse protection assay as previously described (Ray et al., 1989) . Antisense mRNA probes were synthesized with T7 RNA polymerase using [ 32 P]UTP. Labeled antisense probes were hybridized overnight with total cellular RNA at 568C. Free probe and single stranded RNA were digested with a mixture of RNAses A and T1 at 308C for 45 min followed by the addition of proteinase K to inactivate RNAses. The protected RNA was recovered by phenol/ chloroform extraction, ethanol precipitation and analysed by a urea-polyacrylamide gel (5%) electrophoresis followed by autoradiography.
In vitro reporter gene assay NIH3T3 cells were cotransfected with 4 mg of Bcl-x Luc (Yasushi et al., 1997) reporter construct (Bcl-x promoter linked with a luciferase reporter gene), and 2 or 4 mg of CMVMBP-1 (Ray and Miller, 1991) eector plasmid using lipofectamine. After 48 h of transfection, luciferase activity was measured as described earlier (Ghosh et al., 2000) .
